337 related articles for article (PubMed ID: 10424279)
1. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
[TBL] [Abstract][Full Text] [Related]
2. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines.
Fiorucci S; Santucci L; Antonelli E; Distrutti E; Del Sero G; Morelli O; Romani L; Federici B; Del Soldato P; Morelli A
Gastroenterology; 2000 Feb; 118(2):404-21. PubMed ID: 10648469
[TBL] [Abstract][Full Text] [Related]
3. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.
Toyabe S; Seki S; Iiai T; Takeda K; Shirai K; Watanabe H; Hiraide H; Uchiyama M; Abo T
J Immunol; 1997 Aug; 159(3):1537-42. PubMed ID: 9233653
[TBL] [Abstract][Full Text] [Related]
4. Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice.
Nakashima H; Kinoshita M; Nakashima M; Habu Y; Shono S; Uchida T; Shinomiya N; Seki S
Hepatology; 2008 Dec; 48(6):1979-88. PubMed ID: 18942689
[TBL] [Abstract][Full Text] [Related]
5. LPS induces NK1.1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells.
Takahashi M; Ogasawara K; Takeda K; Hashimoto W; Sakihara H; Kumagai K; Anzai R; Satoh M; Seki S
J Immunol; 1996 Apr; 156(7):2436-42. PubMed ID: 8786302
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism.
Li B; Sun R; Wei H; Gao B; Tian Z
Hepatology; 2006 Jun; 43(6):1211-9. PubMed ID: 16729307
[TBL] [Abstract][Full Text] [Related]
7. Involvement of NK1+ T cells and their IFN-gamma production in the generalized Shwartzman reaction.
Ogasawara K; Takeda K; Hashimoto W; Satoh M; Okuyama R; Yanai N; Obinata M; Kumagai K; Takada H; Hiraide H; Seki S
J Immunol; 1998 Apr; 160(7):3522-7. PubMed ID: 9531314
[TBL] [Abstract][Full Text] [Related]
8. 1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α.
Jakubowski A; Sternak M; Jablonski K; Ciszek-Lenda M; Marcinkiewicz J; Chlopicki S
Int Immunopharmacol; 2016 Feb; 31():98-104. PubMed ID: 26709075
[TBL] [Abstract][Full Text] [Related]
9. CD49a promotes T-cell-mediated hepatitis by driving T helper 1 cytokine and interleukin-17 production.
Chen Y; Peng H; Chen Y; Wei H; Sun R; Tian Z
Immunology; 2014 Mar; 141(3):388-400. PubMed ID: 24164540
[TBL] [Abstract][Full Text] [Related]
10. Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells.
Matsui K; Yoshimoto T; Tsutsui H; Hyodo Y; Hayashi N; Hiroishi K; Kawada N; Okamura H; Nakanishi K; Higashino K
J Immunol; 1997 Jul; 159(1):97-106. PubMed ID: 9200444
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis.
Lee WY; Salmi M; Kelly MM; Jalkanen S; Kubes P
Hepatology; 2013 Oct; 58(4):1413-23. PubMed ID: 23686782
[TBL] [Abstract][Full Text] [Related]
12. A novel accessory role of neutrophils in concanavalin A-induced hepatitis.
Hatada S; Ohta T; Shiratsuchi Y; Hatano M; Kobayashi Y
Cell Immunol; 2005 Jan; 233(1):23-9. PubMed ID: 15893298
[TBL] [Abstract][Full Text] [Related]
13. Early IFN-gamma production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections.
Antúnez MI; Cardoni RL
Immunol Lett; 2001 Dec; 79(3):189-96. PubMed ID: 11600197
[TBL] [Abstract][Full Text] [Related]
14. The differential effects of low dose and high dose concanavalin A on cytokine profile and their importance in liver injury.
Xu X; Wei H; Dong Z; Chen Y; Tian Z
Inflamm Res; 2006 Apr; 55(4):144-52. PubMed ID: 16807695
[TBL] [Abstract][Full Text] [Related]
15. Kupffer cells contribute to concanavalin A-induced hepatic injury through a Th1 but not Th17 type response-dependent pathway in mice.
Chen L; Xie XJ; Ye YF; Zhou L; Xie HY; Xie QF; Tian J; Zheng SS
Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):171-8. PubMed ID: 21459724
[TBL] [Abstract][Full Text] [Related]
16. Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency.
Di Marco R; Xiang M; Zaccone P; Leonardi C; Franco S; Meroni P; Nicoletti F
Autoimmunity; 1999 Oct; 31(2):75-83. PubMed ID: 10680745
[TBL] [Abstract][Full Text] [Related]
17. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice.
Louis H; Le Moine O; Peny MO; Quertinmont E; Fokan D; Goldman M; Devière J
Hepatology; 1997 Jun; 25(6):1382-9. PubMed ID: 9185757
[TBL] [Abstract][Full Text] [Related]
18. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
[TBL] [Abstract][Full Text] [Related]
19. Impaired NK cell cytotoxicity by high level of interferon-gamma in concanavalin A-induced hepatitis.
Dong Z; Zhang C; Wei H; Sun R; Tian Z
Can J Physiol Pharmacol; 2005 Nov; 83(11):1045-53. PubMed ID: 16391713
[TBL] [Abstract][Full Text] [Related]
20. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury.
Wang J; Sun R; Wei H; Dong Z; Tian Z
Int Immunopharmacol; 2006 May; 6(5):800-7. PubMed ID: 16546711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
